Metraipolis › archive › dc_03344bcc4d88

Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms — Europe PMC PMID:41228192

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228192
DOI
10.3390/cancers17213397
License (as archived)
solo-consultazione
Archived
2026-11-09T03:55:57.411Z
SHA-256 of the archived text
6e716491979a43dd0cf99b2585fd04d4cb0c4ba1296d46bfd29eaa88be36f312
Stable URL of this page
https://metraipolis.com/documento/dc_03344bcc4d88

How to cite

Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms — Europe PMC PMID:41228192 — Europe PMC (en), https://europepmc.org/article/MED/41228192 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03344bcc4d88 (Metraipolis archive dc_03344bcc4d88, sha256 6e716491979a43dd0cf99b2585fd04d4cb0c4ba1296d46bfd29eaa88be36f312)
BibTeX
@misc{dc03344bcc4d88,
  title = {Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms — Europe PMC PMID:41228192},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228192},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03344bcc4d88; sha256 6e716491979a43dd0cf99b2585fd04d4cb0c4ba1296d46bfd29eaa88be36f312},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228192. Agents can read the archived copy with the MCP tool read_document.